Beacon Financial Advisory LLC Purchases 600 Shares of CVS Health Co. (NYSE:CVS)

Beacon Financial Advisory LLC grew its holdings in shares of CVS Health Co. (NYSE:CVS) by 4.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,088 shares of the pharmacy operator’s stock after acquiring an additional 600 shares during the quarter. Beacon Financial Advisory LLC’s holdings in CVS Health were worth $632,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health during the third quarter valued at approximately $25,000. Ridgewood Investments LLC boosted its position in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares during the period. Livelsberger Financial Advisory purchased a new position in shares of CVS Health in the third quarter valued at about $31,000. Legacy Investment Solutions LLC bought a new position in shares of CVS Health during the third quarter valued at about $31,000. Finally, Reston Wealth Management LLC purchased a new position in CVS Health during the 3rd quarter valued at about $32,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Down 1.3 %

NYSE CVS opened at $55.62 on Thursday. The stock’s 50-day moving average price is $51.11 and its 200-day moving average price is $56.06. The company has a market capitalization of $69.99 billion, a P/E ratio of 14.12, a price-to-earnings-growth ratio of 0.62 and a beta of 0.61. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same period last year, the firm earned $2.21 EPS. The company’s revenue was up 6.3% on a year-over-year basis. On average, equities research analysts predict that CVS Health Co. will post 5.14 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.78%. CVS Health’s payout ratio is 67.51%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $60.00 to $66.00 in a research note on Monday, November 18th. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Barclays dropped their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research report on Tuesday, December 3rd. Finally, Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. One research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $68.12.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.